Artificial Intelligence

The WODMDX 2026 expo returns to Shanghai, leveraging a unique 'precision matching' model to connect global tech with China's industrial giants.

Retired NASA astronaut and UMD alumna Dr. Jeanette Epps will inspire the Class of 2026, bringing her story of 'fearless determination' back to campus.

Absci will showcase its generative AI drug discovery platform at a key healthcare conference, highlighting its ambitious pipeline for hair loss and endometriosis.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

As uranium prices soar, one explorer uses advanced 3D modeling and AI to unlock new discovery potential in Canada's richest uranium district.

As Spectral AI preps its revolutionary DeepView wound scanner for launch, new CFO David McGuire brings crucial public company expertise to a pivotal transition.

Ovid Therapeutics is spotlighting a novel drug class targeting KCC2, a key brain protein. Could this be the key to treating psychosis and epilepsy?

CorTec's brain-computer interface gets FDA Breakthrough status, offering new hope for restoring movement in millions of chronic stroke survivors.

A landmark test proves new 9-1-1 location tech meets federal mandates, offering telecoms a clear path to compliance and promising to save lives.

After years of development, Solar Roadways is deploying its new SR5 panel at a military base and seeking investment to scale its intelligent pavement.

Acclaro Medical's new AuraLux laser combines 'cold ablative' tech with a unique business partnership, aiming to make advanced skin treatments safe for all.

A new survey shows AI-aware customers are forcing brands to rethink everything. Consumers now use their own AI tools for speed, upending traditional CX.

Ann Arbor startup Adrenaline Interactive lands a $1M prize to revolutionize in-game ads, signaling Michigan's push to become a tech innovation hub.

TAE Life Sciences' new therapy combines precision radiation with immunotherapy, showing 100% tumor regression in preclinical studies for hard-to-treat cancers.

Stellar Cyber's 'Most Innovative' award at RSAC 2026 highlights a major shift toward AI that empowers, not replaces, human security experts.

Contrary to hype, AI in drug discovery demands more physical lab work. A new report names Carterra a key winner in this surprising new paradigm.

Celebrating a decade of challenging norms, AESARA eyes its next chapter in global health, armed with AI, RWE, and a focus on complex diseases.

Temasek-backed Xora Innovation hires Eric Rosenblum to lead its U.S. expansion, aiming to capture the next wave of AI and deep tech investment.

Debuting at SIR 2026, DeepSight's NeedleVue Mini aims to democratize advanced procedural guidance by upgrading existing ultrasound systems everywhere.

A new partnership brings AI-powered sentiment analysis to fleets, aiming to solve the costly driver turnover problem by listening to truckers like never before.